Related Experiment Video
Updated: Sep 1, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Complete Right Bundle Branch Block as a Predictor of Cardiovascular Events in Type 2 Diabetes
Katsuhiro Ono1,2, Sadahiko Uchimoto1, Masamune Miyazaki1
1Department of Internal Medicine, Fujiidera Municipal Hospital, Fujiidera 583-0012, Japan.
Insights
Complete right bundle branch block (CRBBB) is a common ECG finding. In type 2 diabetes mellitus (T2DM) patients, CRBBB independently predicts cardiovascular events, including death and heart failure.
Area of Science:
- Cardiology
- Diabetology
- Electrocardiography
Background:
- Complete right bundle branch block (CRBBB) is often considered clinically insignificant.
- Its prognostic value in type 2 diabetes mellitus (T2DM) patients is not well-established.
Purpose of the Study:
- To investigate the association between CRBBB and cardiovascular events in T2DM patients.
- To determine if CRBBB is an independent predictor of adverse cardiovascular outcomes in this population.
Main Methods:
- A single-center cohort study with a 6-year follow-up.
- Analysis of 370 T2DM patients, including those with pre-existing heart disease.
- The Fine-Gray model with inverse probability of treatment weighting was employed.
Main Results:
- CRBBB was present in 9.2% of the T2DM patients.
- Patients with CRBBB had a significantly higher risk of composite cardiovascular events (HR, 2.55; 95% CI, 1.04-6.26; p=0.041).
- This association remained significant after adjusting for confounders.
Conclusions:
- CRBBB is an independent predictor of cardiovascular events in patients with T2DM.
- Further research with larger cohorts is recommended to validate these findings.
Abstract:
Complete right bundle branch block (CRBBB) is generally regarded as a clinically insignificant abnormality on an electrocardiogram, although its predictive value for cardiovascular events in type 2 diabetes mellitus (T2DM) is unknown. We examined the association of CRBBB with cardiovascular events during a 6-year follow-up in a single-center cohort study. The Fine-Gray model was used to analyze the independent association between CRBBB and composite cardiovascular events including cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for heart failure during follow up. We analyzed the data of 370 T2DM patients including 62 patients with pre-existing heart disease. CRBBB was found in 34 patients (9.2%). The composite cardiovascular outcome was recorded in 32 patients. When analyzed with the Fine-Gray model with inverse probability of treatment weighting, CRBBB was significantly associated with a higher risk of the cardiovascular outcome (hazard ratio, 2.55; 95% confidence interval, 1.04 to 6.26; p = 0.041). This association remained significant even after further adjustment for each of the potential confounders. This study suggested that CRBBB was an independent predictor of cardiovascular events in T2DM. Further studies with a larger sample size are warranted.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Coronary Artery Disease I: Introduction
Heart Failure Drugs: β-Blockers
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...